RSS

non-Hodgkin's lymphoma (NHL)

A team, led by Dr Nicole Steinmetz from the Case Western Reserve University Schools of Engineering and Medicine in Cleveland, Ohio, has developed a nanoparticle drug delivery system (nanoDDS) for first-line treatment of Non-Hodgkin's lymphoma (NHL). more

News

Genmab has announced that its collaboration partner for daratumumab, Janssen Biotech, has decided to not initiate stage 2 of the Phase II study. more

News